[go: up one dir, main page]

WO2009026938A3 - Modèle de technologie d'information dans une application pharmaceutique (mitpa) - Google Patents

Modèle de technologie d'information dans une application pharmaceutique (mitpa) Download PDF

Info

Publication number
WO2009026938A3
WO2009026938A3 PCT/EG2008/000028 EG2008000028W WO2009026938A3 WO 2009026938 A3 WO2009026938 A3 WO 2009026938A3 EG 2008000028 W EG2008000028 W EG 2008000028W WO 2009026938 A3 WO2009026938 A3 WO 2009026938A3
Authority
WO
WIPO (PCT)
Prior art keywords
mitpa
model
information technology
pharmaceutical application
report
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EG2008/000028
Other languages
English (en)
Other versions
WO2009026938A2 (fr
Inventor
Mostafa Adel Mansour Hassan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of WO2009026938A2 publication Critical patent/WO2009026938A2/fr
Anticipated expiration legal-status Critical
Publication of WO2009026938A3 publication Critical patent/WO2009026938A3/fr
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/48707—Physical analysis of biological material of liquid biological material by electrical means

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

L'invention vise à éviter les essais cliniques sur les animaux semblables aux êtres humains et à diminuer de manière sensible le nombre de ces essais sur les êtres humains. Elle concerne ainsi une machine formée de trois parties qui comprennent : la machine qui expose le dosage pharmaceutique aux fluides corporels normaux du type salive et à d'autres fluides; le logiciel qui fournit un rapport concernant l'action du médicament dans le corps; et enfin, l'imprimante qui imprime chaque rapport selon l'organe.
PCT/EG2008/000028 2007-08-26 2008-08-25 Modèle de technologie d'information dans une application pharmaceutique (mitpa) Ceased WO2009026938A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EG2007080441 2007-08-26
EG2007080441 2007-08-26

Publications (2)

Publication Number Publication Date
WO2009026938A2 WO2009026938A2 (fr) 2009-03-05
WO2009026938A3 true WO2009026938A3 (fr) 2010-06-10

Family

ID=40387902

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EG2008/000028 Ceased WO2009026938A2 (fr) 2007-08-26 2008-08-25 Modèle de technologie d'information dans une application pharmaceutique (mitpa)

Country Status (1)

Country Link
WO (1) WO2009026938A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10853451B2 (en) 2013-06-06 2020-12-01 Timeless Veterinary Systems International Limited Drug formulary application

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997014962A1 (fr) * 1995-10-18 1997-04-24 John Hopkins University Systeme de modelisation de posologie
US20020042701A1 (en) * 2000-10-06 2002-04-11 Dancu Michael B. System and method to simulate hemodynamics
WO2004109278A1 (fr) * 2003-06-04 2004-12-16 Bc Cancer Agency Procede et systeme permettant de mesurer la penetration de medicaments et autres substances dans un tissu

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997014962A1 (fr) * 1995-10-18 1997-04-24 John Hopkins University Systeme de modelisation de posologie
US20020042701A1 (en) * 2000-10-06 2002-04-11 Dancu Michael B. System and method to simulate hemodynamics
WO2004109278A1 (fr) * 2003-06-04 2004-12-16 Bc Cancer Agency Procede et systeme permettant de mesurer la penetration de medicaments et autres substances dans un tissu

Also Published As

Publication number Publication date
WO2009026938A2 (fr) 2009-03-05

Similar Documents

Publication Publication Date Title
FR2909867B3 (fr) Capsule remplie d'un medicament, en particulier d'un medicament inhalable.
EP2248519A3 (fr) Formes galéniques de film non mucoadhésifs
MX2009002196A (es) Oblea de buprenorfina para terapia de sustitucion de farmacos.
FI3457135T3 (fi) Fabryn taudin hoitovaihtoehtoja
WO2006063189A3 (fr) Systeme d'administration de medicament a desintegration rapide
AR062583A1 (es) Sistema de suministro de farmaco oral gastro-retentivo de liberacion extendida para valsartan
WO2007095598A3 (fr) Procédé de création d'un modèle informatique virtuel de mâchoires
IL180565A0 (en) An improved stopcock for administering medicaments into the patient's body
IL184272A (en) Use of a biological response modifier (BRM) in the preparation of drugs for direct delivery to a secondary lymphoid organ of a subject
WO2010062688A3 (fr) Forme galénique pour insertion dans la bouche
MX374797B (es) Formulaciones farmaceuticas que contienen hidrato de propilenglicol de dapagliflozina.
WO2007062078A3 (fr) Composes modulant l'activite thrombopoietine et procedes correspondants
WO2008011426A3 (fr) Procédés et médicaments destinés à l'administration d'ibuprofène
PE20110711A1 (es) Tratamiento de trastornos cognitivos con (r)-7-cloro-n-(quinuclidin-3-il)benzo[b]tiofeno-2-carboxamida y sales farmaceuticamente aceptables de la misma
WO2008149802A1 (fr) Agent anti-fatigue et composition orale comprenant chacun de l'andrographolide en tant que principe actif
DE60336225D1 (de) Neue pharmazeutische zusammenstezungen, flibanserin polymorph a enthaltend
JP2007520565A5 (fr)
TW200637611A (en) Pharmaceutical for hygienic administration in the ear
WO2009026938A3 (fr) Modèle de technologie d'information dans une application pharmaceutique (mitpa)
UA90893C2 (ru) Пероральная дозированная форма производных гемцитабина
CN101945653B (zh) 用于治疗神经变性疾病的组合物和方法
IL170518A (en) Liquid oral dosage formulations comprising 5-methyl-2-(2'-chloro-6'-fluoroanilino) phenylacetic acid, methods for preparing them and use thereof for the manufacture of medicaments
EP1867641A4 (fr) Médicament prophylactique ou thérapeutique contre la dépression ou la névrose d'angoisse
WO2008009802A3 (fr) Medicaments comprenant un inhibiteur des alpha-mannosidases de classe i pour le traitement des sarcoglycanopathies
WO2008120617A1 (fr) Composition pharmaceutique pour empêcher la progression d'une constriction intestinale associée à la maladie de crohn

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08784488

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08784488

Country of ref document: EP

Kind code of ref document: A2